BusinessPhoto: NDTV ProfitMax Healthcare Q2 Growth Boosted by Occupancy and New Beds
Max Healthcare's Q2 performance received positive ratings from Citi and Jefferies, both maintaining a 'buy' rating. They set price targets of Rs 1,240 and Rs 1,260, respectively, indicating a potential upside of up to 46.5% from the last closing price. Growth was driven by increased occupancy and the addition of new beds.
NDTV Profit·




